These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36914753)

  • 1. Identification of a CEACAM5 targeted nanobody for positron emission tomography imaging and near-infrared fluorescence imaging of colorectal cancer.
    Xiao Y; Mei C; Xu D; Yang F; Yang M; Bi L; Mao J; Pang P; Li D
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2305-2318. PubMed ID: 36914753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIR-II fluorescence imaging-guided colorectal cancer surgery targeting CEACAM5 by a nanobody.
    Guo X; Li C; Jia X; Qu Y; Li M; Cao C; Zhang Z; Qu Q; Luo S; Tang J; Liu H; Hu Z; Tian J
    EBioMedicine; 2023 Mar; 89():104476. PubMed ID: 36801616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immuno-PET of colorectal cancer with a CEA-targeted [68 Ga]Ga-nanobody: from bench to bedside.
    Li L; Lin X; Wang L; Ma X; Zeng Z; Liu F; Jia B; Zhu H; Wu A; Yang Z
    Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3735-3749. PubMed ID: 37382662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homogeneous tumor targeting with a single dose of HER2-targeted albumin-binding domain-fused nanobody-drug conjugates results in long-lasting tumor remission in mice.
    Xenaki KT; Dorrestijn B; Muns JA; Adamzek K; Doulkeridou S; Houthoff H; Oliveira S; van Bergen En Henegouwen PM
    Theranostics; 2021; 11(11):5525-5538. PubMed ID: 33859761
    [No Abstract]   [Full Text] [Related]  

  • 5. Preclinical evaluation of a novel EGFR&c-Met bispecific near infrared probe for visualization of esophageal cancer and metastatic lymph nodes.
    Liang M; Wang L; Xiao Y; Yang M; Mei C; Zhang Y; Shan H; Li D
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2787-2801. PubMed ID: 37145165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Albumin binding improves nanobody pharmacokinetics for dual-modality PET/NIRF imaging of CEACAM5 in colorectal cancer models.
    Song W; Wei W; Lan X; Cai W
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(9):2591-2594. PubMed ID: 37191678
    [No Abstract]   [Full Text] [Related]  

  • 7. PEGylated Fluorescent Anti-carcinoembryonic Antigen Antibody Labels Colorectal Cancer Tumors in Orthotopic Mouse Models.
    Turner MA; Amirfakhri S; Nishino H; Neel NC; Hosseini M; Cox KE; Lwin TM; Li L; Hong T; Sherman A; Shively JE; Hoffman RM; Yazaki PJ; Bouvet M
    J Surg Res; 2023 Nov; 291():596-602. PubMed ID: 37540977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (18)F-nanobody for PET imaging of HER2 overexpressing tumors.
    Xavier C; Blykers A; Vaneycken I; D'Huyvetter M; Heemskerk J; Lahoutte T; Devoogdt N; Caveliers V
    Nucl Med Biol; 2016 Apr; 43(4):247-52. PubMed ID: 27067045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimodality PET and Near-Infrared Fluorescence Intraoperative Imaging of CEA-Positive Colorectal Cancer.
    Lwin TM; Minnix M; Li L; Sherman A; Hong T; Wong JYC; Olafsen T; Poku E; Bouvet M; Fong Y; Shively JE; Yazaki PJ
    Mol Imaging Biol; 2023 Aug; 25(4):727-734. PubMed ID: 37341873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis.
    Li Q; Li Y; Li J; Ma Y; Dai W; Mo S; Xu Y; Li X; Cai S
    Int J Biol Sci; 2018; 14(7):726-735. PubMed ID: 29910683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEACAM5-Targeted Immuno-PET in Androgen Receptor-Negative Prostate Cancer.
    Imberti C; De Gregorio R; Korsen JA; Hoang TT; Khitrov S; Kalidindi T; Nandakumar S; Park J; Zaidi S; Pillarsetty NVK; Lewis JS
    J Nucl Med; 2024 Jul; 65(7):1043-1050. PubMed ID: 38782457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
    Chatalic KL; Veldhoven-Zweistra J; Bolkestein M; Hoeben S; Koning GA; Boerman OC; de Jong M; van Weerden WM
    J Nucl Med; 2015 Jul; 56(7):1094-9. PubMed ID: 25977460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Dye and Conjugation Chemistry on the Biodistribution Profile of Near-Infrared-Labeled Nanobodies as Tracers for Image-Guided Surgery.
    Debie P; Van Quathem J; Hansen I; Bala G; Massa S; Devoogdt N; Xavier C; Hernot S
    Mol Pharm; 2017 Apr; 14(4):1145-1153. PubMed ID: 28245129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid tumor-labeling kinetics with a site-specific near-infrared anti-CEA nanobody in a patient-derived orthotopic xenograft mouse model of colon cancer.
    Lwin TM; Turner MA; Amirfakhri S; Nishino H; Debie P; Cosman BC; Hoffman RM; Hernot S; Bouvet M
    J Surg Oncol; 2021 Dec; 124(7):1121-1127. PubMed ID: 34309885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanobody-targeted photodynamic therapy induces significant tumor regression of trastuzumab-resistant HER2-positive breast cancer, after a single treatment session.
    Deken MM; Kijanka MM; Beltrán Hernández I; Slooter MD; de Bruijn HS; van Diest PJ; van Bergen En Henegouwen PMP; Lowik CWGM; Robinson DJ; Vahrmeijer AL; Oliveira S
    J Control Release; 2020 Jul; 323():269-281. PubMed ID: 32330574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
    Pruszynski M; Koumarianou E; Vaidyanathan G; Revets H; Devoogdt N; Lahoutte T; Lyerly HK; Zalutsky MR
    J Nucl Med; 2014 Apr; 55(4):650-6. PubMed ID: 24578241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ImmunoPET/NIRF/Cerenkov multimodality imaging of ICAM-1 in pancreatic ductal adenocarcinoma.
    Li M; Wei W; Barnhart TE; Jiang D; Cao T; Fan K; Engle JW; Liu J; Chen W; Cai W
    Eur J Nucl Med Mol Imaging; 2021 Aug; 48(9):2737-2748. PubMed ID: 33537836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein Receptor CEACAM5-Targeted Intraoperative Molecular Imaging Tracer in Non-Small Cell Lung Cancer.
    Azari F; Kennedy GT; Chang A; Bernstein E; Nadeem B; Pèlegrin A; Cailler F; Sullivan NT; Kucharczuk J; Singhal S
    Ann Thorac Surg; 2023 Sep; 116(3):631-641. PubMed ID: 35644263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific near-infrared nanobody probe rapidly labels tumors in an orthotopic mouse model of pancreatic cancer.
    Lwin TM; Hernot S; Hollandsworth H; Amirfakhri S; Filemoni F; Debie P; Hoffman RM; Bouvet M
    Surgery; 2020 Jul; 168(1):85-91. PubMed ID: 32370916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo near-infrared fluorescence targeting of T cells: comparison of nanobodies and conventional monoclonal antibodies.
    Bannas P; Well L; Lenz A; Rissiek B; Haag F; Schmid J; Hochgräfe K; Trepel M; Adam G; Ittrich H; Koch-Nolte F
    Contrast Media Mol Imaging; 2014; 9(2):135-42. PubMed ID: 24523058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.